US Stock MarketDetailed Quotes

Compass Therapeutics (CMPX)

Watchlist
  • 5.700
  • -0.100-1.72%
Close Jan 16 16:00 ET
  • 5.730
  • +0.030+0.53%
Post 20:01 ET
1.01BMarket Cap-12.67P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics (CMPX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
850K
0
0
850K
0
0
0
Operating revenue
--0
--0
--0
--850K
--0
--0
--850K
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
29.23%15.82M
32.53%21.07M
40.69%17.97M
14.12%57.48M
7.67%16.57M
2.62%12.24M
19.18%15.9M
31.50%12.77M
20.91%50.36M
19.44%15.39M
Selling and administrative expenses
-17.54%2.99M
-1.48%4.65M
51.23%4.91M
23.61%15.13M
19.18%3.54M
17.19%3.63M
51.61%4.72M
5.69%3.25M
5.02%12.24M
0.24%2.97M
-General and administrative expense
-17.54%2.99M
-1.48%4.65M
51.23%4.91M
23.61%15.13M
19.18%3.54M
17.19%3.63M
51.61%4.72M
5.69%3.25M
5.02%12.24M
0.24%2.97M
Research and development costs
48.93%12.83M
46.90%16.42M
37.09%13.05M
11.08%42.34M
4.93%13.04M
-2.48%8.61M
9.30%11.17M
43.45%9.52M
27.08%38.12M
25.16%12.43M
Operating profit
-29.23%-15.82M
-40.02%-21.07M
-40.69%-17.97M
-12.43%-56.63M
-7.67%-16.57M
-2.62%-12.24M
-12.81%-15.05M
-31.50%-12.77M
-20.91%-50.36M
-19.44%-15.39M
Net non-operating interest income expense
-11.38%1.56M
-39.06%1.2M
-7.59%7.3M
-20.81%1.59M
-10.40%1.76M
-4.37%1.97M
234.75%7.9M
55.26%2.01M
Non-operating interest income
-11.38%1.56M
-39.06%1.2M
----
-7.59%7.3M
-20.81%1.59M
-10.40%1.76M
-4.37%1.97M
----
234.75%7.9M
55.26%2.01M
Other net income (expense)
-15K
-32.78%1.33M
-61.29%-50K
5.82%1.98M
-144.29%-31K
Special income (charges)
----
----
----
----
----
----
--0
----
----
----
-Gain on sale of property,plant,equipment
----
----
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
----
---15K
-32.78%1.33M
-61.29%-50K
----
----
----
5.82%1.98M
---31K
----
Income before tax
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
Income tax
0
0
0
0
0
Net income
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
Net income continuous Operations
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
Minority interest income
Net income attributable to the parent company
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
Basic earnings per share
0.00%-0.08
-40.00%-0.14
-50.00%-0.12
-9.09%-0.36
-10.00%-0.11
0.00%-0.08
-11.11%-0.1
-33.33%-0.08
10.81%-0.33
0.00%-0.1
Diluted earnings per share
0.00%-0.08
-40.00%-0.14
-50.00%-0.12
-9.09%-0.36
-10.00%-0.11
0.00%-0.08
-11.11%-0.1
-33.33%-0.08
10.81%-0.33
0.00%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 000850K00850K000
Operating revenue --0--0--0--850K--0--0--850K--0--0--0
Cost of revenue
Gross profit
Operating expense 29.23%15.82M32.53%21.07M40.69%17.97M14.12%57.48M7.67%16.57M2.62%12.24M19.18%15.9M31.50%12.77M20.91%50.36M19.44%15.39M
Selling and administrative expenses -17.54%2.99M-1.48%4.65M51.23%4.91M23.61%15.13M19.18%3.54M17.19%3.63M51.61%4.72M5.69%3.25M5.02%12.24M0.24%2.97M
-General and administrative expense -17.54%2.99M-1.48%4.65M51.23%4.91M23.61%15.13M19.18%3.54M17.19%3.63M51.61%4.72M5.69%3.25M5.02%12.24M0.24%2.97M
Research and development costs 48.93%12.83M46.90%16.42M37.09%13.05M11.08%42.34M4.93%13.04M-2.48%8.61M9.30%11.17M43.45%9.52M27.08%38.12M25.16%12.43M
Operating profit -29.23%-15.82M-40.02%-21.07M-40.69%-17.97M-12.43%-56.63M-7.67%-16.57M-2.62%-12.24M-12.81%-15.05M-31.50%-12.77M-20.91%-50.36M-19.44%-15.39M
Net non-operating interest income expense -11.38%1.56M-39.06%1.2M-7.59%7.3M-20.81%1.59M-10.40%1.76M-4.37%1.97M234.75%7.9M55.26%2.01M
Non-operating interest income -11.38%1.56M-39.06%1.2M-----7.59%7.3M-20.81%1.59M-10.40%1.76M-4.37%1.97M----234.75%7.9M55.26%2.01M
Other net income (expense) -15K-32.78%1.33M-61.29%-50K5.82%1.98M-144.29%-31K
Special income (charges) --------------------------0------------
-Gain on sale of property,plant,equipment --------------------------0------------
Other non- operating income (expenses) -------15K-32.78%1.33M-61.29%-50K------------5.82%1.98M---31K----
Income before tax -36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M
Income tax 00000
Net income -36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M
Net income continuous Operations -36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M
Minority interest income
Net income attributable to the parent company -36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M
Basic earnings per share 0.00%-0.08-40.00%-0.14-50.00%-0.12-9.09%-0.36-10.00%-0.110.00%-0.08-11.11%-0.1-33.33%-0.0810.81%-0.330.00%-0.1
Diluted earnings per share 0.00%-0.08-40.00%-0.14-50.00%-0.12-9.09%-0.36-10.00%-0.110.00%-0.08-11.11%-0.1-33.33%-0.0810.81%-0.330.00%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -